Page 1 of 1INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.1. Company Name and Address4. EPA ProductRegistrationOMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460DATA CALL-IN RESPONSE3. Date and Type of DCI and NumberPRODUCT SPECIFIC17-Mar-2010ID # PDCI-035602-273012. Case # and Name2135 Dazomet, and saltsChemical # and Name035602Dazomet5. I wish tocancel thisproduct registration voluntarily6. Generic Data7. Product Specific Data7a. My product is an MUP andI agree to satisfy the MUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."7b. My product is an EUP andI agree to satisfy the EUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."6a. I am claiming a GenericData Exemption because Iobtain the active ingredientfrom the source EPA registration number listed below.6b. I agree to satisfy GenericData requirements as indicatedon the attached form entitled"Requirements Status andRegistrant's Response."N.A.N.A.10. Name of Company11. Phone Number9. Date8. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. I acknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.Signature and Title of Company's Authorized Representative__________________________________INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 1 of 4OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC17-Mar-2010PDCI-035602-273012. Case # and Name2135 Dazomet, and salts8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321Product Chemistry Data Requirements (ConventionalChemical)(41)830.15508TGAI/MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LProduct Identity and composition(42)830.16008TGAI/MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LDescription of materials used to produce the product(43)830.16208TGAIH, I, K, D, M, A, B, C, J,N, O, E, F, G, LDescription of production process(44)830.16508MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LDescription of formulation process(45)830.16708TGAI/MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LDiscussion of formation of impurities(1 ,2 ,46)830.17008TGAIH, I, K, D, M, A, B, C, J,N, O, E, F, G, LPreliminary analysis(47)830.17508TGAI/MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LCertified limits(48)830.18008TGAI/MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LEnforcement analytical method(3)830.63028TGAI/MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LColor(4)830.63038TGAI/MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LPhysical state(5)830.63048TGAI/MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LOdor12. Name of Company13. Phone NumberSignature and Title of Company's Authorized Representative__________________________________10. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. Iacknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law11. DateINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 2 of 4OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC17-Mar-2010PDCI-035602-273012. Case # and Name2135 Dazomet, and salts8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(6 ,7 ,49)830.63138TGAIH, I, K, D, M, A, B, C, J,N, O, E, F, G, LStability to normal and elevated temperatures,metals, and metal ions(8)830.63148MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LOxidizing or reducing action(9)830.63158MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LFlammability(10)830.63168MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LExplodability(11 ,50)830.631716MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LStorage stability(12)830.63198MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LMiscibility(13 ,51)830.632016MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LCorrosion characteristics(14)830.63218MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LDielectric breakdown voltage(15 ,16)830.70008TGAI/MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LpH830.70508TGAI/PAIH, I, K, D, M, A, B, C, J,N, O, E, F, G, LUV/Visible absorption(17)830.71008MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LViscosity(18 ,19)830.72008TGAIH, I, K, D, M, A, B, C, J,N, O, E, F, G, LMelting point/melting rangeInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 3 of 4OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC17-Mar-2010PDCI-035602-273012. Case # and Name2135 Dazomet, and salts8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(20 ,21)830.72208TGAIH, I, K, D, M, A, B, C, J,N, O, E, F, G, LBoiling point/boiling range(22 ,23)830.73008TGAI/MP/EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LDensity/relative density(24 ,25)830.73708TGAI or PAIH, I, K, D, M, A, B, C, J,N, O, E, F, G, LDissociation constants in water(26)830.75508TGAI/PAIH, I, K, D, M, A, B, C, J,N, O, E, F, G, LPartition coefficient (n-octanol/water), shake flaskmethod(27)830.75708TGAI/PAIH, I, K, D, M, A, B, C, J,N, O, E, F, G, LPartition coefficient (n-octanol/water), estimation byliquid chromatography(28)830.78408TGAI or PAIH, I, K, D, M, A, B, C, J,N, O, E, F, G, LWater solubility: Column elution method, shake flaskmethod(29)830.78608TGAI or PAIH, I, K, D, M, A, B, C, J,N, O, E, F, G, LWater solubility, generator column method(30 ,31)830.79508TGAI or PAIH, I, K, D, M, A, B, C, J,N, O, E, F, G, LVapor pressureToxicology Data Requirements (Conventional Chemical)(32 ,52)870.11008TGAI,EP,dilute EP?H, I, K, D, M, A, B, C, J,N, O, E, F, G, LAcute Oral Toxicity(33 ,34 ,53)870.12008TGAI,EP,dilute EP?H, I, K, D, M, A, B, C, J,N, O, E, F, G, LAcute dermal toxicity(35)870.13008TGAI & EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LAcute inhalation toxicityInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 4 of 4OMB Approval 2070-0107OMB Approval 2070-0057United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC17-Mar-2010PDCI-035602-273012. Case # and Name2135 Dazomet, and salts8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(36)870.24008TGAI & EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LAcute eye irritation(37 ,38)870.25008TGAI & EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LAcute dermal irritation(39 ,40)870.26008TGAI & EPH, I, K, D, M, A, B, C, J,N, O, E, F, G, LSkin sensitizationInitial to indicate certification as to information on this page (fulltext of certification is on page one).DateCase # and Name:2135 Dazomet, and saltsDCI Number:PDCI-035602-27301Page 1 of 4[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSTGAI & EP = Technical Grade of the Active Ingredient and End-Use Product; TGAI or PAI = Technical Grade of the Active Ingredient or Pure Active Ingredient; TGAI = Technical Grade ActiveIngredient [TGAI]; MP/EP = Manufacturing-Use Product, Pure Active Ingredient; TGAI,EP,dilute EP? = Technical Grade of the Active Ingredient, End Use Product, and possibly diluted End UseProduct; TGAI/MP/EP = Manufacturing-Use Product, Pure Active Ingredient and Technical Grade Active Ingredient; TGAI/PAI = Technical Grade Active Ingredient, Pure Active IngredientUse Categories Key:A-B -C -Terrestrial food cropTerrestrial feed cropTerrestrial nonfood cropD -E -F -Aquatic food cropAquatic nonfood outdoor useAquatic nonfood industrial useG -H -I -Aquatic non-food residentialGreenhouse food cropGreenhouse nonfood cropJ -K -L - Indoor food useResidentialForestry useM -N -O -Indoor nonfood useIndoor medical useResidential Indoor use1Required for TGAIs and products produced by an integrated system.2If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).3If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).4If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).5If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).6If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).7Data on the stability to metals and metal ions is required only if the active ingredient is expected to come in contact with either material during storage.8Required if the product contains an oxidizing or reducing agent9Required when the product contains combustible liquids.10Required when the product is potentially explosive.11Please see attached "Additional Information and Requirements Pertaining to Storage Stability (OPPTS 830.6317) and Corrosion Characteristics (OPPTS 830.6320) Data Requirements of theProduct Specific Data Call-Ins issued under the Reregistration Eligibility Decision (RED)/Interim Reregistration Eligibility Decision (IRED) Documents."12Required if the product is an emulsifiable liquid and is to be diluted with petroleum solvents.13Please see attached "Additional Information and Requirements Pertaining to Storage Stability (OPPTS 830.6317) and Corrosion Characteristics (OPPTS 830.6320) Data Requirements of theProduct Specific Data Call-Ins issued under the Reregistration Eligibility Decision (RED)/Interim Reregistration Eligibility Decision (IRED) Documents."14Required if the end-use product is a liquid and is to be used around electrical equipment.15If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).Case # and Name:2135 Dazomet, and saltsDCI Number:PDCI-035602-27301Page 2 of 4[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSTGAI & EP = Technical Grade of the Active Ingredient and End-Use Product; TGAI or PAI = Technical Grade of the Active Ingredient or Pure Active Ingredient; TGAI = Technical Grade ActiveIngredient [TGAI]; MP/EP = Manufacturing-Use Product, Pure Active Ingredient; TGAI,EP,dilute EP? = Technical Grade of the Active Ingredient, End Use Product, and possibly diluted End UseProduct; TGAI/MP/EP = Manufacturing-Use Product, Pure Active Ingredient and Technical Grade Active Ingredient; TGAI/PAI = Technical Grade Active Ingredient, Pure Active Ingredient16Required if the product is dispersible with water.17Required if the product is a liquid.18If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).19Required when the TGAI is solid at room temperature.20If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).21Required if the TGAI is liquid at room temperature.22If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).23True density or specific density are required for all test substances. Data on bulk density is required for MPs that are solidat room temperature.24If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).25Required when the test substance contains an acid or base functionality (organic or inorganic) or an alcoholic functionality (organic).26Required if the TGAI or PAI is organic and non-polar.27Required if the TGAI or PAI is organic and non-polar.28If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).29If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).30If the TGAI cannot be isolated, data are required on the practical equivalent of the TGAI (i.e., if the active ingredient is either an acid, base or ionic form, and it is formulated into salts or esters,the concentration of the active ingredient in these products must be expressed in acid equivalent or active equivalent).Case # and Name:2135 Dazomet, and saltsDCI Number:PDCI-035602-27301Page 3 of 4[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSTGAI & EP = Technical Grade of the Active Ingredient and End-Use Product; TGAI or PAI = Technical Grade of the Active Ingredient or Pure Active Ingredient; TGAI = Technical Grade ActiveIngredient [TGAI]; MP/EP = Manufacturing-Use Product, Pure Active Ingredient; TGAI,EP,dilute EP? = Technical Grade of the Active Ingredient, End Use Product, and possibly diluted End UseProduct; TGAI/MP/EP = Manufacturing-Use Product, Pure Active Ingredient and Technical Grade Active Ingredient; TGAI/PAI = Technical Grade Active Ingredient, Pure Active Ingredient31Not required for salts.32Not required if test material is a gas or a highly volatile liquid.33Not required if test material is a gas or a highly volatile liquid.34Not required if test material is corrosive to skin or has a pH of less than 2 or greater than 11.5.35Required if the product consists of, or under conditions of use will result in, a respirable material (e.g., gas, vapor, aerosol, or particulate).36Not required if test material is corrosive to skin or has a pH of less than 2 or greater than 11.5.37Not required if test material is a gas or a highly volatile liquid.38Not required if test material is corrosive to skin or has a pH of less than 2 or greater than 11.5.39Not required if test material is corrosive to skin or has a pH of less than 2 or greater than 11.5.40Required if repeated dermal exposure is likely to occur under conditions of use.41Data must be provided in accordance with 40 CFR Part 158.320.42Data must be provided in accordance with 40 CFR Part 158.325.43Data must be provided in accordance with 40 CFR Part 158.330.44Data must be provided in accordance with 40 CFR Part 158.335.45Data must be provided in accordance with 40 CFR Part 158.340.Case # and Name:2135 Dazomet, and saltsDCI Number:PDCI-035602-27301Page 4 of 4[The following notes are referenced in column two (5. Study File) of the REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE form.]Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSTGAI & EP = Technical Grade of the Active Ingredient and End-Use Product; TGAI or PAI = Technical Grade of the Active Ingredient or Pure Active Ingredient; TGAI = Technical Grade ActiveIngredient [TGAI]; MP/EP = Manufacturing-Use Product, Pure Active Ingredient; TGAI,EP,dilute EP? = Technical Grade of the Active Ingredient, End Use Product, and possibly diluted End UseProduct; TGAI/MP/EP = Manufacturing-Use Product, Pure Active Ingredient and Technical Grade Active Ingredient; TGAI/PAI = Technical Grade Active Ingredient, Pure Active Ingredient46Data must be provided in accordance with 40 CFR Part 158.345.47Data must be provided in accordance with 40 CFR Part 158.350.48Data must be provided in accordance with 40 CFR Part 158.355.49Data on stability of the MP and TGAI to storage at normal temperatures are required. Data on the stability of the TGAI to hightemperatures are required if the TGAI is expected to be subjectedto temperatures >50 degrees Celsius (122 degrees Fahrenheit) during production or storage.50The 16-month deadline for submission of this study applies if you are conducting a new study for submission to the Agency to satisfy this requirement. In such case, you are required to submit aprogress report to the Agency within 3 months following the deadline for submission of the 90-Day response required for thisPDCI. Further information concerning the development of dataappears on page 7 of the Generic and Product Specific Data Call-In Notice. If you intend to submit an existing study that hasnot been submitted previously to the Agency or to cite previouslysubmitted data, the existing study or citation to the previously submitted study must be submitted along with your 90-Day Response to this PDCI. If the Agency determines that such existingdata are not adequate, you will need to develop and submit new data within the stated deadline.51The 16-month deadline for submission of this study applies if you are conducting a new study for submission to the Agency to satisfy this requirement. In such case, you are required to submit aprogress report to the Agency within 3 months following the deadline for submission of the 90-Day response required for this PDCI. Further information concerning the development of dataappears on page 7 of the Generic and Product Specific Data Call-In Notice. If you intend to submit an existing study that hasnot been submitted previously to the Agency or to cite previouslysubmitted data, the existing study or citation to the previously submitted study must be submitted along with your 90-Day Response to this PDCI. If the Agency determines that such existingdata are not adequate, you will need to develop and submit new data within the stated deadline.52Diluted EP testing is required to support the end product registration if results using the EP meet the criteria for restricted use classification under 40 CFR Part 152.170(b) or special reviewconsideration under 40 CFR Part 154.7(a)(1).53Diluted EP testing is required to support the end product registration if results using the EP meet the criteria for restricted use classification under 40 CFR Part 152.170(b) or special reviewconsideration under 40 CFR Part 154.7(a)(1).United States Environmental ProtectionAgency Washington, D.C. 20460LIST OF ALL REGISTRANTS SENT THIS DATA CALL-IN NOTICECo. Nr.Company NameAgent ForAddressCity & StateZipCase # and Name:2135,Dazomet, and saltsBUCKMAN LABORATORIES INC.1256 NORTH MCLEAN BLVDMEMPHISTN381081448BASF CORPORATIONPO Box 13528 26 DAVIS DRIVERESEARCHTRIANGLE PARKNC2770935287969NALCO COMPANY1601 WEST DIEHL ROADNAPERVILLEIL6056311981706BASF CORPORATION100 CAMPUS DRIVEFLORHAM PARKNJ0793233753CERTIS USA, LLC9145 GUILFORD ROAD, SUITE 175COLUMBIAMD2104670051DR. WOLMAN GMBHTOXCELPO Box 363 7140 HERITAGE VILLAGE PLAZAGAINESVILLEVA2015671406VALUE GARDENS SUPPLY, LLCPO Box 585SAINT JOSEPHMO64502769VERICHEM, INC.3499 GRAND AVENUEPITTSBURGHPA1522567869KEMIRA CHEMICALS, INC,1950 VAUGHAN ROADKENNESAWGA301449386